patients with oncology
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.No gender restrictions; 2.Age >=18 and =3, or PG-SGA score >=4, or Expected inability to achieve >=60% of recommended oral intake for >1 week; 5.Hepatic and renal function: ALT/AST <=2.5×ULN (<=5×ULN for liver metastasis) ALP <=2.5×ULN (<=5×ULN for liver metastasis) Total bilirubin (TBIL) <1.5×ULN Serum creatinine (SCr) <1.5×ULN Triglycerides (TG) <1.5×ULN[(Note: ULN = upper limit of normal)]; 6.Tolerable to enteral nutrition; 7.Willing to provide written informed consent.
Exclusion criteria
Exclusion criteria: 1.Intolerance or inability to receive oral/enteral tube feeding; 2.Conditions severely affecting digestion/absorption of study products: Acute pancreatitis Gastrointestinal failure Complete intestinal obstruction Active gastrointestinal bleeding Severe diarrhea or other malabsorption disorders; 3.Current use of other nutritional preparations that may interfere with study outcomes; 4.Comorbid major organ dysfunction, multiple organ failure, or severe metabolic disorders; 5.Cancer cachexia patients; 6.Pregnant/lactating women or women of childbearing potential with positive baseline pregnancy test; 7.Known allergy to any component of the investigational product; 8.Investigator's judgment of unsuitability for participation;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| prealbumin;weight; | — |
Secondary
| Measure | Time frame |
|---|---|
| Gastrointestinal reactions;liver and kidney function;handgrip;walking speed; | — |
Countries
China
Contacts
Peking Union Medical College Hospital